Position history for NATIXIS's holdings in Inhibrx Biosciences, Inc.
NATIXIS holds 889 shares of INBX (Inhibrx Biosciences, Inc.), worth $70,231 as of 2025-Q4. The position was decreased (-55.5% shares). INBX represents 0.0% of NATIXIS's portfolio.
Current Value
$70,231
Current Shares
889
Total Value Change
+$41,891
Total Shares Change
-1,111
Other major holders of INBX: VIKING GLOBAL INVESTORS LP, MORGAN STANLEY, HighTower Advisors, LLC, BlackRock, Inc.
Decreased |
| 889 |
-55.5% |
| $70,231 |
| 0.0% |
| $77.98 |
0 |
| 2025-Q3 | Unchanged | 2,000 | 0.0% | $67,360 | 0.0% | $32.31 | 0 |
| 2025-Q2 | Unchanged | 2,000 | 0.0% | $28,540 | 0.0% | $14.43 | 0 |
| 2025-Q1 | Unchanged | 2,000 | 0.0% | $27,480 | 0.0% | $14.12 | 0 |
| 2024-Q4 | Unchanged | 2,000 | 0.0% | $30,800 | 0.0% | $15.14 | 0 |
| 2024-Q3 | Unchanged | 2,000 | 0.0% | $31,320 | 0.0% | $15.52 | 0 |
| 2024-Q2 | New | 2,000 | - | $28,340 | 0.0% | $14.17 | 27 |